Home/Edgewood Oncology/David N. Cook, Ph.D.

DN

David N. Cook, Ph.D.

Chief Executive Officer

Edgewood Oncology

Therapeutic Areas

Edgewood Oncology Pipeline

Drug	Indication	Phase
BTX-A51	Acute Myeloid Leukemia (AML)	Phase 1

Leadership Team at Edgewood Oncology

Zung Thai, M.D., Ph.D.

Chief Medical Officer

Yinon Ben-Neriah, M.D., Ph.D.

Scientific Founder

View full Edgewood Oncology profile